Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

Autor: Javier Sastre, Milagros Balbín, Guillermo Quintero, Virginia Moreno Moral, Virginia de la Orden, Antonio Martínez, Beatriz Mediero, Inmaculada Bando, Patricia Llovet, Enrique Aranda, Maria José Ortiz-Morales, Sarai Palanca, Pilar García-Alfonso, Jose María Vieitez, Antonieta Salud, Silvia Gil Calle, Beatriz Bellosillo, Carlos F. Lopez, Eduardo Díaz-Rubio, Maria Isabel Peligros Gomez

Publikováno v: CLINICAL COLORECTAL CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

This is a post hoc analysis of biomarkers from a large cohort of patients with chemo-naive metastatic colorectal cancer. Both high baseline circulating tumor cell count and RAS mutated were associated with clinical or pathologic features classically

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a78c3a95ccb833e35acfc857a74349
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12606

Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs)

Autor: Rafael López, Antonieta Salud Salvia, Eduardo Díaz-Rubio, Begoña Graña Suárez, Beatriz García Paredes, Silvia Gil Calle, Rocio Garcia-Carbonero, Carmen Guillen, Maria Jose Safont, Javier Sastre, Guillermo Alfonso Quintero Aldana, Maria Auxilidora Gomez-España, Encarnación González Flores, Eva Martínez de Castro, Mercedes Salgado Fernández, Juan José Reina-Zoilo, Enrique Aranda, Pilar García-Alfonso, Jose María Vieitez, Adelaida La Casta Munoa

Publikováno v: Journal of Clinical Oncology. 37:3507-3507

3507 Background: FOLFOXIRI+BEV has demonstrated a survival benefit compared with FOLFIRI plus BEV (TRIBE Lancet Oncol 2015) in first-line mCRC. Nevertheless, due to its safety profile, this schedule is not recommended for all pts. In addition, we hav

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2d02914911952b4ab67d86c7d1f8fb3
https://doi.org/10.1200/jco.2019.37.15_suppl.3507

Bronchiolitis obliterans organizing pneumonia simulating progression in bronquioloalveolar carcinoma

Autor: Julia Alcaide García, Manuel Benavides Orgaz, Ester Villar Chamorro, Silvia Gil Calle, Vanesa Gutiérrez Calderón, Manuel Cobo Dols, Inmaculada Alés Díaz

Publikováno v: Clinical and Translational Oncology. 8:133-135

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome with characteristic features. The diagnosis of BOOP requires the presence of a combination of pathological, clinical, and radiological features. We report the case o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8329343628d4ea1b91393fff3e0bcd5f
https://doi.org/10.1007/s12094-006-0171-0

Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy

Autor: Julia Alcalde García, Francisco Carabantes Ocón, Inmaculada Alés Díaz, Manuel Benavides Orgaz, Vanesa Gutiérrez Calderón, Silvia Gil Calle, Esther Villar Chamorro, Alvaro Montesa Pino, Juan José Bretón García, Manuel Cobo Dols

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(10)

Objective. We conducted this phase II trial to evaluate the efficacy and toxicity of the sequential nonplatinum combination chemotherapy consisting of gemcitabine (GEM) and vinorelbine (VNR) followed by weekly docetaxel (DOC) in patients with advance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6308a0c704fdab08166f04f633785c
https://pubmed.ncbi.nlm.nih.gov/17074673

Solitary metastasis in a nasal fossa as the first manifestation of a renal carcinoma

Autor: Manuel Cobo-Dols, Inmaculada Alés-Díaz, Julia Alcaide-García, Vanesa Gutiérrez-Calderón, Álvaro Montesa-Pino, Ester Villar-Chamorro, Silvia Gil-Calle, Manuel Benavides-Orgaz

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(4)

Renal cell carcinoma is an uncommon tumor in adults. metastasis in the nasal fossa is rare, and can become apparent as a result of repeated epistaxis. We report a patient with renal cell carcinoma presenting with epistaxis secondary to a metastasis i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7554e3bfab8748edfd95e97b4ebeef3
https://pubmed.ncbi.nlm.nih.gov/16648109